Related Experiment Video

Updated: Jul 11, 2026

Mouse Models for Graft Arteriosclerosis
07:37

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

Aspirin and alcohol in gastrointestinal haemorrhage

C D Needham, J Kyle, P F Jones

    Gut
    |October 1, 1971
    PubMed

    Insights

    Aspirin significantly increases gastrointestinal bleeding risk. While alcohol alone does not, combining aspirin and alcohol creates a potent synergistic effect, greatly elevating hemorrhage risk in patients.

    Area of Science:

    • Gastroenterology
    • Clinical Medicine
    • Epidemiology

    Background:

    • Gastrointestinal hemorrhage is a significant clinical concern.
    • Understanding the role of common substances like aspirin and alcohol in its etiology is crucial.
    • Previous studies have suggested potential links, but the specific interactions require further elucidation.

    Purpose of the Study:

    • To investigate the association between aspirin and alcohol consumption and the incidence of gastrointestinal hemorrhage.
    • To determine if alcohol alone, aspirin alone, or a combination of both substances poses a greater risk.
    • To analyze these risks across different diagnostic groups of gastrointestinal bleeding.

    Main Methods:

    • A case-control study involving 817 patients admitted for gastrointestinal hemorrhage.
    • Comparison of substance ingestion (aspirin, alcohol, or both) between patient groups and two control groups.
    • Statistical analysis to assess the significance of associations and synergistic effects.

    Main Results:

    • A markedly significant association was confirmed between overt gastrointestinal hemorrhage and aspirin ingestion.
    • Alcohol consumption alone did not show a significant association with hemorrhage.
    • The combination of aspirin and alcohol demonstrated a highly significant synergistic effect on hemorrhage risk.

    Conclusions:

    • Aspirin is a significant risk factor for gastrointestinal hemorrhage.
    • Alcohol alone does not appear to be a primary risk factor for gastrointestinal hemorrhage.
    • Concurrent use of aspirin and alcohol presents a substantially elevated and synergistic risk for gastrointestinal bleeding.

    Related Concept Videos

    Prevention of Further Absorption of Poison01:14

    Prevention of Further Absorption of Poison

    In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
    Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

    Anticoagulant Drugs: Low-Molecular-Weight Heparins

    Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
    Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

    Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

    The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
    Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
    Gastritis-II: Pathophysiology01:17

    Gastritis-II: Pathophysiology

    Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
    In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
    In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
    Gastritis can stem from various causes, each...
    Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

    Factors Influencing Drug Absorption: Disease States and Pharmacology

    Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
    Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
    Drug toxicity: Drug–Drug Interaction01:30

    Drug toxicity: Drug–Drug Interaction

    Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...